
Biotechnology and Applied Biochemistry (2002) 36, (163170) (Printed in Great Britain)
Modified high amylose starch for immobilization of uricase for therapeutic application
Jérome Mulhbacher*, Kevin McGeeney, Pompilia Ispas-Szabo*, Vincent Lenaerts and Mircea-Alexandru Mateescu*1
*Department of Chemistry and Biochemistry, Université du Québec à Montréal, C.P. 8888, Succ. A, Montréal, Québec, Canada H3C 3P8, Department of Medicine and Therapeutics, University College Dublin, Dublin, Ireland, and Labopharm Inc., Laval, Québec, Canada
Correction to this paper
Key words: enzyme therapy, gout, joints inflammation, uricase, uric acid.
Abbreviations used: AE-HASCL-35, aminoethyl high amylose starch cross-linked 35; CM-HASCL-35, carboxymethyl high amylose starch cross-linked 35; DNS, dinitrosalicylic acid; EDAC, 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide.
1To whom correspondence should be addressed (e-mail mateescu.m-alexandru@uqam.ca).
Urate oxidase (uricase) was immobilized on carboxymethyl high amylose starch cross-linked 35 (CM-HASCL-35), on aminoethyl high amylose starch cross-linked 35, as well as on commercial supports, CNBr-activated Sepharose and diaminodipropylamine agarose. The N-ethyl-5-phenylisoxazolium-3´-sulphonate (Woodward reagent K) gave a high binding but totally inhibited the enzyme activity. Best results were obtained with CM-HASCL-35 using 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide as a coupling agent. The immobilized enzyme retained 88% of its initial limit rate [Vmax(app) = 16 EU/mg for immobilized uricase versus Vmax = 18 EU/mg for the free enzyme], with an apparent decrease of affinity for urate substrate [Km(app) = 0.17 mM versus Km = 0.03 mM for the free enzyme]. The coupling yield was 60% and the modified uricase was found more resistant to proteolysis than the free enzyme. The immobilized uricase retained 25% of its initial activity after 60 min in pancreatic proteolysis medium (pancreatin), whereas the free enzyme retained only 5% of its initial activity. The best immobilization yield was obtained with the polymeric support based on CM-HASCL-35 (53%), which gave better results than commercial supports based on agarose.
Received 9 April 2002/23 July 2002; accepted 25 July 2002
Portland Press Ltd ©
2002
|